DK0695172T3 - Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse - Google Patents

Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse

Info

Publication number
DK0695172T3
DK0695172T3 DK94911799T DK94911799T DK0695172T3 DK 0695172 T3 DK0695172 T3 DK 0695172T3 DK 94911799 T DK94911799 T DK 94911799T DK 94911799 T DK94911799 T DK 94911799T DK 0695172 T3 DK0695172 T3 DK 0695172T3
Authority
DK
Denmark
Prior art keywords
preparation
fast
release solid
active agent
solid preparation
Prior art date
Application number
DK94911799T
Other languages
English (en)
Inventor
Jean Paul Remon
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of DK0695172T3 publication Critical patent/DK0695172T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94911799T 1993-04-22 1994-04-21 Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse DK0695172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9300407A BE1006990A5 (nl) 1993-04-22 1993-04-22 Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
PCT/BE1994/000029 WO1994023700A1 (en) 1993-04-22 1994-04-21 High release solid preparation, preparation and use thereof

Publications (1)

Publication Number Publication Date
DK0695172T3 true DK0695172T3 (da) 1998-08-24

Family

ID=3886999

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911799T DK0695172T3 (da) 1993-04-22 1994-04-21 Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse

Country Status (12)

Country Link
US (1) US6368634B1 (da)
EP (1) EP0695172B1 (da)
JP (1) JP2960169B2 (da)
AT (1) ATE161174T1 (da)
AU (1) AU6421594A (da)
BE (1) BE1006990A5 (da)
CA (1) CA2161016A1 (da)
DE (1) DE69407404T2 (da)
DK (1) DK0695172T3 (da)
ES (1) ES2113095T3 (da)
GR (1) GR3026338T3 (da)
WO (1) WO1994023700A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318577A1 (de) * 1993-06-04 1994-12-08 Merck Patent Gmbh Schmiermittelfreie, arzneimittelhaltige Tabletten
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
AU9321198A (en) * 1997-10-07 1999-04-27 Fuisz Technologies Ltd. Dosage forms having improved release properties
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
JP4632288B2 (ja) * 2002-02-27 2011-02-16 塩野義製薬株式会社 難水溶性薬物の吸収性を改善した固形状製剤
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
EP2051696A2 (en) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020262536A1 (en) 2019-06-26 2020-12-30 Ricoh Company, Ltd. Instantly soluble particle and method for producing the same
CA3144945A1 (en) 2019-06-26 2020-12-30 Ricoh Company, Ltd. Pharmaceutical composition including particles containing a water-soluble base material and a poorly water-soluble compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1148802A (en) * 1965-06-18 1969-04-16 Eastman Kodak Co Microcrystalline cellulose granules containing useful oils
CH523017A (de) * 1969-11-21 1972-05-31 Agripat Sa Schädlingsbekämpfungsmittel
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
GB1367608A (en) * 1973-03-09 1974-09-18 Biolog Concepts Inc Oral pharmaceutical dosage form
USRE33963E (en) * 1981-10-29 1992-06-16 Bayer Aktiengesellschaft Solid rapidly released medicament preparations containing dihydropyridines, and processes for their preparation
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DD249186A1 (de) * 1986-05-26 1987-09-02 Univ Halle Wittenberg Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法

Also Published As

Publication number Publication date
DE69407404T2 (de) 1998-07-02
DE69407404D1 (de) 1998-01-29
CA2161016A1 (en) 1994-10-27
ES2113095T3 (es) 1998-04-16
JP2960169B2 (ja) 1999-10-06
AU6421594A (en) 1994-11-08
ATE161174T1 (de) 1998-01-15
BE1006990A5 (nl) 1995-02-07
JPH09500093A (ja) 1997-01-07
US6368634B1 (en) 2002-04-09
EP0695172B1 (en) 1997-12-17
GR3026338T3 (en) 1998-06-30
WO1994023700A1 (en) 1994-10-27
EP0695172A1 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
BR9713866A (pt) Composição farmacéutica
MXPA01006926A (es) Formulaciones para tratar enfermedades y metodos para usar las mismas.
GB9416600D0 (en) Pharmaceutical formulation
AR003908A1 (es) Tableta de liberacion controlada
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
PL318789A1 (en) Sprayable film-forming system capable to release an active substance contained in them and intended to use them on plants
EE03202B1 (et) Intravaginaalne manustussüsteem ja selle valmistamismeetod
ZA945546B (en) Antifugal nail solution
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
MX9605678A (es) Produccion de composiciones de sustancia activa en forma de una solucion solida de la sustancia activa en una matriz de polimero, y composiciones de sustancia activa producidas por este procedimiento.
GT199800126A (es) Terapia de combinacion.
HUP0000143A2 (hu) Kétfázisú eljárások esszenciális aminosavak felhalmozódásának növelésére magokban
GR3022572T3 (en) Controlled release matrix for pharmaceuticals
HRP920960B1 (en) Solutionless pharmaceutical preparations for oral use retardely releasing an active substance and a process for the preparation thereof
CA2286710A1 (fr) Dispositif d'insemination artificielle pour animaux d'elevage tels que, notamment, truies______________________________________________________
DE69431162D1 (en) Fenbendazolformulierungen
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ES2120514T3 (es) Formulacion solida para la proteccion de cultivos.
DE69418257T2 (de) Trennmittelzufuhrsystem
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
NO20004981D0 (no) Kontrollert frigivningstablett fremstilt fra lineære vannuoppløselige polysakkarider
ES2130069A1 (es) Preparacion farmaceutica con liberacion retardada del producto activo.